Ludivine S. Breger

Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain

Poonam Thakur, Ludivine S. Breger, Martin Lundblad et al. · Proceedings of the National Academy of Sciences · 2017 · 247 citations · Full text

Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD

Deirdre B. Hoban, Shelby Shrigley, Bengt Mattsson et al. · Proceedings of the National Academy of Sciences · 2020 · 57 citations · Full text

Synaptic Transmission, Immunology, Therapeutics +21

Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats

Tim Fieblinger, Lucia Zanetti, Irene Sebastianutto et al. · Scientific Reports · 2018 · 51 citations · Full text

Synaptic Transmission, Neurotransmitter, Clinical Neuroscience +24

A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses

Abdelwahed Chtarto, Marie Humbert‐Claude, Olivier Bockstael et al. · Molecular Therapy — Methods & Clinical Development · 2016 · 50 citations · Full text

Antimicrobial Chemotherapy, Antiviral Drug, Glioma +27

Comparison of rating scales used to evaluate l-DOPA-induced dyskinesia in the 6-OHDA lesioned rat

Ludivine S. Breger, Stephen B. Dunnett, Emma L. Lane · Neurobiology of Disease · 2012 · 36 citations · Full text

Physiology, Neuropharmacology, Neuroscience +6